2020 | |
---|---|
Criterium: | Position: |
Overall Score: | 400-500 |
Total Project Funding per Partner: | 200-300 |
Total Number of Projects: | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2020 | 0 | 17.768.150 | 6.731.111 | 3 |
Total number of partners: 26
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 23
Frequent / Rare Partner Ratio: 0.13
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2020-08-01 | Evaluation of ratioNally Designed Influenza vaccines | ENDFLU | participant | 8.646.254 | 14 |
2020-03-01 | Monoclonal Antibodies against 2019-New Coronavirus | MANCO | participant | 3.034.581 | 8 |
2020-01-01 | Improved Vaccination Strategies for Older Adults | ISOLDA | participant | 6.087.314 | 7 |